SAN DIEGO--(BUSINESS WIRE)--The California Healthcare Institute (CHI) will host “Keeping Pace with Technology: Molecular Diagnostics Regulation and Reimbursement,” Wednesday, Sept. 17, 10:00 a.m. to 6:00 p.m. at Gen-Probe Incorporated in San Diego - located at 10210 Genetic Center Drive, San Diego, Calif. 92121. This forum will feature many national experts in molecular diagnostics technology, reimbursement and regulation industry including: Mari Baker, president and chief executive officer, Navigenics, Inc.; Jeff Bush, director of corporate reimbursement, BD; Robert DiTullio, vice president of regulatory affairs and quality, ProteoGenix, Inc.; Alberto Gutierrez, Ph.D., deputy director, Office of In Vitro Diagnostic Device (OIVD) Safety and Evaluation, Center for Devices and Radiological Health (CDRH), FDA; Sheri Hall, vice president of regulatory affairs and quality, BD; Richard Jove, Ph.D.; director, Beckman Research Institute, City of Hope; Hank Nordhoff, chairman and CEO, Gen-Probe Incorporated; Hakan Sakul, Ph.D.; senior director and global head of diagnostics, Pfizer Global Research and Development; Patrick Terry, co-founder and director, Consumer Advocacy and Governmental Affairs, Genomic Health; and Tim Wolleager, managing director, Sanderling Ventures.
